Abstract
Background: Cholestasis may lead to hepatic cirrhosis and a longer hospital stay. A part of the patients with cholestasis requires liver transplantation. However, most of the treatment efficiency of cholestatic hepatitis (CH) is not satisfactory. For the patients with severe CH after artificial liver support, there was a lack of systemic evaluation on the treatment efficiency of double plasma molecular absorption system (DPMAS) for acute severe CH. Objective: We aim to investigate the treatment efficiency of DPMAS on acute severe CH. Methods: This retrospective study involved 309 cases diagnosed with acute severe CH admitted to the First Affiliated Hospital, Zhejiang University. We compared the prognosis of patients received standard medical therapy (SMT) and SMT + DPMAS. Besides, the effects of DPMAS on total bilirubin (TBIL) and prothrombin time (PT) were investigated. Results: DPMAS could significantly reduce the requirements for liver transplantation in the CH patients. After DPMAS therapy, significant decline was noticed in the TBIL, direct bilirubin (DBIL), total bile acid, and cholesterol. The baseline ratio of neutrophil showed significant elevation in the patients received 4 or more DPMAS compared with those received less DPMAS. Conclusions: DPMAS could significantly eliminate the necessity of liver transplantation. The artificial liver support system should be conducted to bring down the bilirubin level and the ratio of cases with severe conditions. In general, DPMAS should be preferred as an artificial liver support therapy for the patients with acute severe CH.
References
1.
Pollock
G
, Minuk
GY
. Diagnostic considerations for cholestatic liver disease
. J Gastroenterol Hepatol
. 2017 Jul
;32
(7
):1303
–9
. .2.
Holoman
J
, Glasa
J
. EASL clinical practice guidelines
. J Hepatol
. 2009
;51
(4
):821
–2
.3.
ECotuoecotdatocl
. Expert consensus on the diagnosis and treatment of cholestatic liver disease: an update in 2015
. Linchuang Gandanbing Zazhi
. 2015
.4.
Fabris
P
, Tositti
G
, Mazzella
G
, Zanetti
AR
, Nicolin
R
, Pellizzer
G
, Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study
. Aliment Pharmacol Ther
. 1999 Sep
;13
(9
):1187
–93
. .5.
Invernizzi
P
, Setchell
KD
, Crosignani
A
, Battezzati
PM
, Larghi
A
, O'Connell
NC
, Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis
. Hepatology
. 1999 Feb
;29
(2
):320
–7
. .6.
Daghman
D
, Rez
MS
, Soltany
A
, Alsaleh
A
. Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients
. Oxf Med Case Reports
. 2019 Aug
;2019
(8
):omz080
. .7.
Noureddin
M
, Sander-Struckmeier
S
, Mato
JM
. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: a systematic review
. World J Hepatol
. 2020 Feb 27
;12
(2
):46
–63
. .8.
Hirschfield
GM
, Dyson
JK
, Alexander
GJM
, Chapman
MH
, Collier
J
, Hübscher
S
, The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines
. Gut
. 2018 Sep
;67
(9
):1568
–94
. .9.
Guideline for diagnosis and treatment of liver failure
. Zhonghua Gan Zang Bing Za Zhi
. 2019 Jan 20
;27
(1
):18
–26
.10.
Alshamsi
F
, Alshammari
K
, Belley-Cote
E
, Dionne
J
, Albrahim
T
, Albudoor
B
, Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials
. Intensive Care Med
. 2020 Jan
;46
(1
):1
–16
. .11.
Yao
J
, Li
S
, Zhou
L
, Luo
L
, Yuan
L
, Duan
Z
, Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure
. J Clin Apher
. 2019 Aug
;34
(4
):392
–8
. .12.
Rolo
AP
, Palmeira
CM
, Wallace
KB
. Mitochondrially mediated synergistic cell killing by bile acids
. Biochim Biophys Acta
. 2003 Jan 20
;1637
(1
):127
–32
. .13.
Ma
X
, Wen
JX
. Paeonia lactiflora Pall. regulates the NF-κB-NLRP3 inflammasome pathway to alleviate cholestasis in rats
. 2018 Dec
;70
(12
):1675
–87
.14.
Diagnostic and treatment guidelines for liver failure (2019 version)
. Chin J Hepatol
. 2019
;27
(1
):18
–26
.15.
Steadman
RH
, Van Rensburg
A
, Kramer
DJ
. Transplantation for acute liver failure: perioperative management
. Curr Opin Organ Transplant
. 2010 Jun
;15
(3
):368
–73
. .16.
Ling
Q
, Xu
X
, Wei
Q
, Liu
X
, Guo
H
, Zhuang
L
, Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure
. PloS One
. 2012
;7
(1
):e30322
. .17.
Jeong
SH
, Lee
HS
. Hepatitis A: clinical manifestations and management
. Intervirology
. 2010
;53
(1
):15
–9
. .18.
Oketani
M
, Ido
A
, Nakayama
N
, Takikawa
Y
, Naiki
T
, Yamagishi
Y
, Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009
. Hepatol Res
. 2013 Feb
;43
(2
):97
–105
. .19.
Fujiwara
K
, Yokosuka
O
, Inoue
K
, Yasui
S
, Abe
R
, Oda
S
, Distribution of core hospitals for patients with fulminant hepatitis and late onset hepatic failure in Japan
. Hepatol Res
. 2016 Jan
;46
(1
):10
–2
. .20.
Li
LJ
, Zhang
YM
, Liu
XL
, Du
WB
, Huang
JR
, Yang
Q
, Artificial liver support system in China: a review over the last 30 years
. Ther Apher Dial
. 2006 Apr
;10
(2
):160
–7
. .21.
Chen
JJ
, Huang
JR
, Yang
Q
, Xu
XW
, Liu
XL
, Hao
SR
, Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China
. Hepatobiliary Pancreat Dis Int
. 2016 Jun
;15
(3
):275
–81
. .22.
Marques
PE
, Amaral
SS
, Pires
DA
, Nogueira
LL
, Soriani
FM
, Lima
BH
, Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure
. Hepatology
. 2012 Nov
;56
(5
):1971
–82
. .23.
Liu
H
, Zhang
H
, Wan
G
, Sang
Y
, Chang
Y
, Wang
X
, Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure
. J Viral Hepat
. 2014 Jul
;21
(7
):499
–507
. .24.
Fan
Z
, EnQiang
C
, Yao
DL
, LiBo
Y
, Hong
L
, Lang
B
, Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system
. PloS One
. 2017
;12
(4
):e0175332
. .25.
Wan
YM
, Li
YH
, Xu
ZY
, Yang
J
, Yang
LH
, Xu
Y
, Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir: a prospective study
. J Clin Apher
. 2017 Dec
;32
(6
):453
–61
.© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
